FDA Unveils “National Priority Voucher” Program to Shave Drug Review Times
- June 20, 2025
The Food and Drug Administration (FDA) announced June 17 a new “Commissioner’s National Priority Voucher” program aimed at drastically shortening the agency’s review time for new drug applications from the current ten to 12 months to one to two months.
ARTICLE TAGS
You must be logged in to access this content.